Related references
Note: Only part of the references are listed.PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma
Federica Ganci et al.
CLINICAL CANCER RESEARCH (2020)
p53, cancer and the immune response
Julianne Blagih et al.
JOURNAL OF CELL SCIENCE (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N=4532)
M. Montopoli et al.
ANNALS OF ONCOLOGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Respiratory Virus Infections: Understanding COVID-19
Kanta Subbarao et al.
IMMUNITY (2020)
Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
Matteo Allegretti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Cancer at the time of the COVID-19 hurricane
Giovanni Blandino
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Drug repurposing against COVID-19: focus on anticancer agents
Gennaro Ciliberto et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
TMPRSS2 and COVID-19: serendipity or Opportunity for Intervention?
Konrad H. Stopsack et al.
CANCER DISCOVERY (2020)
A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cancer, ACC) do after the pandemic wave?
Nicola Silvestris et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells
Mahrou Vahabi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability
Sourabh Soni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Mutant p53 in cancer therapy-the barrier or the path
Xiang Zhou et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2019)
The Role of microRNAs in the Viral Infections
Mona Fani et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
p53 shades of Hippo
Noa Furth et al.
CELL DEATH AND DIFFERENTIATION (2018)
Altered peritumoral microRNA expression predicts head and neck cancer patients with a high risk of recurrence
Federica Ganci et al.
MODERN PATHOLOGY (2017)
Head and Neck Squamous Cell Carcinomas Are Characterized by a Stable Immune Signature Within the Primary Tumor Over Time and Space
Oliver Wood et al.
CLINICAL CANCER RESEARCH (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins
Silvia Di Agostino et al.
EMBO REPORTS (2016)
The role of MicroRNAs in human cancer
Yong Peng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
Anna Diez-Villanueva et al.
EPIGENETICS & CHROMATIN (2015)
Metabolic control of YAP and TAZ by the mevalonate pathway
Giovanni Sorrentino et al.
NATURE CELL BIOLOGY (2014)
Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
S. Masciarelli et al.
ONCOGENE (2014)
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Meital Gabay et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients
F. Ganci et al.
ANNALS OF ONCOLOGY (2013)
MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
S. Donzelli et al.
CELL DEATH AND DIFFERENTIATION (2012)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
Type II Transmembrane Serine Proteases
Thomas H. Bugge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Share Paper
